RnRMarketResearch.com adds “Renal Artery Stenosis Global Clinical Trials Review, H2, 2014” report to its research database.

Dallas, TX -- (SBWire) -- 10/09/2014 --“Renal Artery Stenosis Global Clinical Trials Review, H2, 2014? provides data on the Renal Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Artery Stenosis.

Complete Report Details
http://www.rnrmarketresearch.com/renal-artery-stenosis-global-clinical-trials-review-h2-2014-market-report.html

Renal artery stenosis is the narrowing of the renal artery, most often caused by atherosclerosis or fibromuscular dysplasia. This narrowing of the renal artery can impede blood flow to the target kidney. Hypertension and atrophy of the affected kidney may result from renal artery stenosis, ultimately leading to renal failure if not treated.

Signs and symptoms

Most cases of renal artery stenosis are asymptomatic, and the main problem is high blood pressure that cannot be controlled with medication. Deterioration in renal function may develop if both kidneys are poorly supplied, or when treatment with an ACE inhibitor is initiated. Some patients present with episodes of flash pulmonary edema (sudden left ventricular heart failure).

Order a Purchase copy
http://www.rnrmarketresearch.com/contacts/purchase?rname=217363

Scope:

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy:

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies.

Browse more reports on Clinical Trial Market
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Artery Stenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Artery Stenosis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Renal Artery Stenosis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Guerbet SA 31
Clinical Trial Overview of Guerbet SA 31
Bayer AG 32
Clinical Trial Overview of Bayer AG 32
Stealth Peptides Inc. 33
Clinical Trial Overview of Stealth Peptides Inc. 33
Proportional Technologies, Inc. 34
Clinical Trial Overview of Proportional Technologies, Inc. 34
General Electric Company 35
Clinical Trial Overview of General Electric Company 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Clinical Trial Overview of Top Institutes / Government 37
Guang'anmen Hospital, China Academy of Chinese Medical Sciences 37
Clinical Trial Overview of Guang'anmen Hospital, China Academy of Chinese Medical Sciences 37
Upstate University Hospital 38
Clinical Trial Overview of Upstate University Hospital 38
Imam Khomeini Hospital 39
Clinical Trial Overview of Imam Khomeini Hospital 39
University of Toledo 40
Clinical Trial Overview of University of Toledo 40
Instytut Kardiologii 41
Clinical Trial Overview of Instytut Kardiologii 41
Azienda Ospedaliera Universitaria Policlinico catania 42
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 42
Mayo Clinic 43
Clinical Trial Overview of Mayo Clinic 43
National Heart, Lung, and Blood Institute 44
Clinical Trial Overview of National Heart, Lung, and Blood Institute 44
Five Key Clinical Profiles 45
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67